BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: West CM, Davidson SE, Burt PA, Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. Int J Radiat Oncol Biol Phys. 1995;31:841-846. [PMID: 7860397 DOI: 10.1016/0360-3016(94)00508-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Jianshe Y, Xigang J, Wenjian L, Zhuanzi W, Guangming Z, Jufang W, Bingrong D, Qingxiang G, Linda W. Correlation between. initial chromatid damage and survival of various cell lines exposed to heavy charged particles. Radiat Environ Biophys. 2006;45:261-266. [PMID: 16964490 DOI: 10.1007/s00411-006-0063-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Chapman JD, Stobbe CC, Matsumoto Y. Chromatin compaction and tumor cell radiosensitivity at 2 gray. Am J Clin Oncol 2001;24:509-15. [PMID: 11586106 DOI: 10.1097/00000421-200110000-00019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
3 Haikonen J, Rantanen V, Pekkola K, Kulmala J, Grénman R. Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual? Int J Cancer 2003;103:784-8. [PMID: 12516099 DOI: 10.1002/ijc.10890] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
4 Yan D, Chen S, Krauss DJ, Deraniyagala R, Chen P, Ye H, Wilson G. Inter/intra-tumoral dose response variations assessed using FDG-PET/CT feedback images: Impact on tumor control and treatment dose prescription. Radiother Oncol 2021;154:235-42. [PMID: 33035624 DOI: 10.1016/j.radonc.2020.09.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Rose PG. Are the differences in treatment outcome for adenocarcinoma of the cervix different enough to change the treatment paradigm? Gynecol Oncol 2012;125:285-6. [PMID: 22482933 DOI: 10.1016/j.ygyno.2012.03.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
6 Kennedy AS, Raleigh JA, Perez GM, Calkins DP, Thrall DE, Novotny DB, Varia MA. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays. International Journal of Radiation Oncology*Biology*Physics 1997;37:897-905. [DOI: 10.1016/s0360-3016(96)00539-1] [Cited by in Crossref: 134] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
7 Bhosle SM, Huilgol NG, Mishra KP. Apoptotic index as predictive marker for radiosensitivity of cervical carcinoma: Evaluation of membrane fluidity, biochemical parameters and apoptosis after the first dose of fractionated radiotherapy to patients. Cancer Detection and Prevention 2005;29:369-75. [DOI: 10.1016/j.cdp.2005.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
8 Miyakawa A, Shibamoto Y, Kosaki K, Hashizume C. Early response and local control of stage I non-small-cell lung cancer after stereotactic radiotherapy: difference by histology. Cancer Sci 2013;104:130-4. [PMID: 23095036 DOI: 10.1111/cas.12048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
9 Núñez MI, McMillan TJ, Valenzuela MT, Ruiz de Almodóvar JM, Pedraza V. Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells. Radiother Oncol 1996;39:155-65. [PMID: 8735483 DOI: 10.1016/0167-8140(96)01732-x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
10 Maeda J, Froning CE, Brents CA, Rose BJ, Thamm DH, Kato TA. Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines. PLoS One 2016;11:e0156689. [PMID: 27257868 DOI: 10.1371/journal.pone.0156689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
11 Menegakis A, De Colle C, Yaromina A, Hennenlotter J, Stenzl A, Scharpf M, Fend F, Noell S, Tatagiba M, Brucker S, Wallwiener D, Boeke S, Ricardi U, Baumann M, Zips D. Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness. Radiother Oncol 2015;116:480-5. [PMID: 26297183 DOI: 10.1016/j.radonc.2015.08.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
12 Crompton NEA, Ozsahin M, Schweizer P, Larsson B, Luetolf UM. Theory and practice of predictive assays in radiation therapy. Strahlenther Onkol 1997;173:58-67. [DOI: 10.1007/bf03038924] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
13 El-Awady RA, Dikomey E, Dahm-Daphi J. Radiosensitivity of human tumour cells is correlated with the induction but not with the repair of DNA double-strand breaks. Br J Cancer 2003;89:593-601. [PMID: 12888835 DOI: 10.1038/sj.bjc.6601133] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
14 Raaphorst G, Malone S, Szanto J, Gray R. Severe normal tissue complication correlates with increased in vitro fibroblast radiosensitivity in radical prostate radiotherapy: A case report. Int J Cancer 2000;90:336-42. [DOI: 10.1002/1097-0215(20001220)90:6<336::aid-ijc5>3.0.co;2-c] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
15 Delaloye JF, Pampallona S, Coucke PA, De Grandi P. Younger age as a bad prognostic factor in patients with carcinoma of the cervix. European Journal of Obstetrics & Gynecology and Reproductive Biology 1996;64:201-5. [DOI: 10.1016/0301-2115(95)02290-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
16 Lee K, Lee J, Park C, Lee K, Cho H, Ha S. What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case–control study. Int J Gynecol Cancer 2006;16:1569-73. [DOI: 10.1111/j.1525-1438.2006.00628.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
17 Mckenna WG, Muschel RJ. Targeting tumor cells by enhancing radiation sensitivity. Genes Chromosom Cancer 2003;38:330-8. [DOI: 10.1002/gcc.10296] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
18 Chen YL, Ho CM, Chen CA, Chiang YC, Huang CY, Hsieh CY, Cheng WF. Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma. Int J Gynaecol Obstet 2011;112:135-9. [PMID: 21130445 DOI: 10.1016/j.ijgo.2010.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Garipagaoglu M, Yalvac S, Kose M, Tulunay G, Kayikcioglu F, Çakmak A, Haberal A, Boran N, Adli M, Hayran M. Treatment results and prognostic factors in inoperable carcinoma of the cervix treated with external plus high dose brachytherapy. Cancer Letters 1999;136:17-26. [DOI: 10.1016/s0304-3835(98)00293-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Yang J, Jing X, Wang Z, Li W. A correlation between radiation sensitivity and initial chromatid breaks in cancer cell lines revealed by Calyculin A-induced premature condensation. Open Life Sciences 2006;1:451-62. [DOI: 10.2478/s11535-006-0028-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Klein KA, Haddock MG. Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer. Radiat Oncol 2013;8:80. [PMID: 23566444 DOI: 10.1186/1748-717X-8-80] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
22 Wilkins RC, Ng CE, Raaphorst GP. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro. Radiat Oncol Investig 1998;6:209-15. [PMID: 9822167 DOI: 10.1002/(SICI)1520-6823(1998)6:5<209::AID-ROI2>3.0.CO;2-G] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Ozsahin M, Ozsahin H, Shi Y, Larsson B, Würgler FE, Crompton NE. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. International Journal of Radiation Oncology*Biology*Physics 1997;38:429-40. [DOI: 10.1016/s0360-3016(97)00038-2] [Cited by in Crossref: 87] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
24 De-Colle C, Yaromina A, Hennenlotter J, Thames H, Mueller AC, Neumann T, Stenzl A, Scharpf M, Fend F, Ricardi U, Baumann M, Zips D, Menegakis A. Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity. Radiother Oncol 2017;124:386-94. [PMID: 28919005 DOI: 10.1016/j.radonc.2017.08.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
25 Yang JS, Li WJ, Zhou GM, Jin XD, Xia JG, Wang JF, Wang ZZ, Guo CL, Gao QX. Comparative study on radiosensitivity of various tumor cells and human normal liver cells. World J Gastroenterol 2005;11:4098-101. [PMID: 15996038 DOI: 10.3748/wjg.v11.i26.4098] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
26 Bristow RG, Benchimol S, Hill RP. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiotherapy and Oncology 1996;40:197-223. [DOI: 10.1016/0167-8140(96)01806-3] [Cited by in Crossref: 121] [Cited by in F6Publishing: 98] [Article Influence: 4.8] [Reference Citation Analysis]
27 Zhou J, Chen Y, Xu X, Yan D, Lou H. Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I-IIB. Medicine (Baltimore) 2018;97:e9323. [PMID: 29480826 DOI: 10.1097/MD.0000000000009323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Lanciano R. Optimizing radiation treatment for cervical cancer. Surg Clin North Am. 2001;81:859-870. [PMID: 11551130 DOI: 10.1016/S0039-6109(05)70170-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
29 Lutgens L, van der Zee J, Pijls-Johannesma M, De Haas-Kock DF, Buijsen J, Mastrigt GA, Lammering G, De Ruysscher DK, Lambin P. Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. Cochrane Database Syst Rev 2010;:CD006377. [PMID: 20238344 DOI: 10.1002/14651858.CD006377.pub3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
30 Walsh S, van der Putten W. A TCP model for external beam treatment of intermediate-risk prostate cancer: A TCP model for prostate cancer. Med Phys 2013;40:031709. [DOI: 10.1118/1.4790469] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
31 Cengel KA, McKenna WG. Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model. Crit Rev Oncol Hematol 2005;55:103-16. [PMID: 16006139 DOI: 10.1016/j.critrevonc.2005.02.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
32 Thrall DE. Biologic basis of radiation therapy. Vet Clin North Am Small Anim Pract 1997;27:21-35. [PMID: 9002164 DOI: 10.1016/s0195-5616(97)50003-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
33 Lutgens L, van der Zee J, Pijls-Johannesma M, De Haas-Kock DF, Buijsen J, Mastrigt GA, Lammering G, De Ruysscher DK, Lambin P. Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma. Cochrane Database Syst Rev 2010;:CD006377. [PMID: 20091593 DOI: 10.1002/14651858.CD006377.pub2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
34 Lanciano R. Optimizing radiation parameters for cervical cancer. Seminars in Radiation Oncology 2000;10:36-43. [DOI: 10.1016/s1053-4296(00)80019-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
35 Buffa FM, Fenwick JD, Nahum AE. An analysis of the relationship between radiosensitivity and volume effects in tumor control probability modeling. Med Phys 2000;27:1258-65. [DOI: 10.1118/1.599003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]